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ABSTRACT

◥

In September 2020, the National Cancer Institute convened the ﬁrst PARTNRS Workshop as an initiative to forge
partnerships between oncologists, primary care professionals, and non-oncology specialists for promoting patient
accrual into cancer prevention trials. This effort is aimed at
bringing about more effective accrual methods to generate
decisive outcomes in cancer prevention research. The workshop convened to inspire solutions to challenges encountered during the development and implementation of cancer
prevention trials. Ultimately, strategies suggested for protocol development might enhance integration of these trials
into community settings where a diversity of patients might
be accrued. Research Bases (cancer research organizations
that develop protocols) could encourage more involvement

Rationale for a Primary Care Alliance
in Cancer Prevention Studies
Clinical detection of both cancer and premalignant
conditions exists within the domain of primary care professionals, who in this respect are the “ﬁrst responders”
and medical “gate-keepers” of the healthcare system (1).
Traditionally, they comprise family physicians, internists,
pediatricians, obstetrician–gynecologists, nurse practitioners,
and physician assistants (2). Yet, the subsequent active consultation and management of frank disease and pre-cancer that
has been detected early necessitates involvement by medical
oncologists, general surgery or surgical subspecialists (e.g.,
colorectal surgeons, urologists, gynecologists), radiologists
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of primary care professionals, relevant prevention specialists,
and patient representatives with protocol development
beginning at the concept level to improve adoptability of
the trials within community facilities, and consider various
incentives to primary care professionals (i.e., remuneration).
Principal investigators serving as liaisons for the NCORP
afﬁliates and sub-afﬁliates, might produce and maintain
“Prevention Research Champions” lists of PCPs and nononcology specialists relevant in prevention research who can
attract health professionals to consider incorporating prevention research into their practices. Finally, patient advocates and community health providers might convince
patients of the beneﬁts of trial-participation and encourage
“shared-decision making.”
(e.g., diagnostic and interventional), and other specialists
(e.g., dermatologists, geneticists, etc.) (3). As such, accruing
participants to cancer prevention trials is highly dependent on
primary care professionals and the numerous specialists
engaged in prevention, detection, and management of premalignant conditions, as well as on the people themselves who are
at risk for cancer (4). However, the recognized gulf in professional communication and coordination between primary care
professionals and oncologists of multiple specialties—surgical,
radiological, and pharmacological—indicates the overdue need
for relational change in these clinical practice settings (5).
Moreover, the chasm between the groups can impede clinical
oncology research, although primary care professionals, particularly Black and Latino physicians, have indicated they are
interested in learning more about cancer clinical trials (6).
Experiences conducting cancer prevention studies through
the National Cancer Institute Community Oncology
Research Program (NCORP) are affected by the accrual
challenges within this cancer care delivery system, and thus
led to the concept and inaugural workshop called “PARTNRS:
The Primary Care Alliance in Research Trials Involving
NCORP Sites.”
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Purpose of the PARTNRS Workshop
The PARTNRS workshop, convened on September 18, 2020,
was developed to improve participant accrual to NCORP-
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supported cancer prevention trials by forging effective partnerships between oncologists, primary care professionals, and
medical specialists. The immediate goal was to establish a
platform for generating strategies to overcome barriers to
accrual. The long-term goal is the establishment of highly
effective accrual methods that support rigorously developed
cancer prevention clinical trials.
Workshop attendees included family physicians, general
internists, nurse practitioners, and specialists in medical, pediatric, surgical and radiation oncology, academicians, NCORP
community oncologists, and clinical administrators. To facilitate a robust discussion, the following organizations were
invited: General medical organizations, including the American Medical Association (AMA), the National Medical Association (NMA), and the National Hispanic Medical Association
(NHMA); internal medicine organizations, such as the American College of Physicians (ACP) and the Society of General
Internal Medicine (SGIM); and advanced practice organizations, such as the American Association of Nurse Practitioners
(AANP). Also participating were the principal investigator and
staff from the NCORP Minority/Underserved Baptist Memorial Health Care/Mid-South. The workshop chairs were the
past presidents of the AMA and the NMA.
NCORP is a national network that brings cancer clinical
trials and care delivery studies to people in their own
communities. The network designs and conducts clinical trials
in cancer prevention, screening, surveillance, supportive care
and symptom management, along with health-related quality
of life and cancer care delivery studies. NCORP investigators
also enroll patients onto cancer treatment trials. NCORP is
committed to integrating health equity research questions
across all studies. By bringing cancer clinical research to
individuals in their own communities, NCORP clinical trials
reﬂect national diversity so the evidence generated contributes
to improved patient outcomes and a reduction in cancer
disparities for all people. The network is comprised of seven
Research Bases and 46 Community Sites, 14 of which are
designated as Minority/Underserved Community Sites, collaborating with more than 9,000 physicians, nurses, and research
staff across the United States. See Fig. 1.

NCORP Research Bases develop the study concepts
and protocols with input from Community and Minority/
Underserved Sites. Sponsored meetings and conferences
provide opportunities to discuss experiences in patient
accrual to cancer prevention trials. Community investigators
often describe protocols as having insufﬁcient input
from primary care providers or non-oncology specialists,
a situation that leads to suboptimal opportunities for engaging these groups as research partners. In addition, primary
care professionals have suggested that integration of
research protocols into their practice must meet the following requisites without cumbersome administrative or regulatory procedures: The protocols must be convenient, not
time-consuming, and without additional costs for interventions; and favorable such that the beneﬁts exceed the perceived risks.
The PARTNRS Workshop tackled the challenges of enrollment into cancer prevention studies by analyzing the roles
and interactions of ﬁve pertinent stakeholders: Research
Bases that produce the protocols; the NCORP Site principal
investigators, who are liaisons between Research Bases and
their afﬁliated community oncologists; the afﬁliated community oncologists; the community non-oncologists (e.g.,
primary care professionals and specialists); and the patients/
participants.
A vital area of discussion was the protocol-production to
protocol-implementation trajectory, from the perspective of
the NCORP Community Sites, which has been characterized as
a “trickle-down” directive process and siloed with lines of
demarcation between each stakeholder instead of an exchange.
See Fig. 2.
Principal investigators also suggested that the Research
Bases were not fully aware of the complexities encountered
when integrating new prevention protocols within the sphere
of routine primary care, where protocols should be aligned
with quality metrics required in the primary care setting.
Quality metrics and maintenance of clinical credentials, such
as clinical medical education credits, and specialty certiﬁcation and recertiﬁcation boards, are important priorities for
primary care providers.
Figure 1.
NCI Community Oncology Research Program locations
of Community and Minority/Underserved Sites throughout the United States.
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Figure 2.
Interactions among stakeholders during the participant accrual process.

Recommendations for the Protocol
Process
Research Bases
Typically, protocol development is a multi-tiered, laborintensive process requiring time commitments that may not
be feasible for primary care professionals, community practitioners, and patient-advocates. There is substantial remodeling in protocol-development, beginning with conceptualizing a protocol, until the protocol is deemed acceptable by
the Research Base to release for review and ﬁnal approval by
the NCI and the Central Institutional Review Board. Upon
receipt of the protocol, the NCORP Community Site principal investigator typically collaborates with an interested
community provider who manages the target population
within a facility. Despite initial efforts to integrate the trial
within the community, requirements can emerge that are
cumbersome for implementation within the clinic. Recommendations are as follows:

4.

5.
1. Develop strategies to promote greater involvement of
primary care professionals, non-oncology specialists,
and patient representatives within the Research Base’s
Prevention Committee. For a target patient population, the
committee can seek representation by primary care
professionals, specialists, and patients during concept and
protocol development, and the NCORP principal
investigator can identify appropriate individuals to inform
the Research Base about the feasibility of integrating the
trial into the community setting without disrupting the
clinic’s daily operations.
2. Promote ways to stimulate the interest of primary care
professionals and non-oncology specialists in
participating in prevention trials. This may come
through ﬁnancial remuneration through partial or full
funding for travel for annual meetings, as well as

AACRJournals.org

6.

enhancing professional development in the area of
clinical research. In addition, “Relative Value Units” may
be the principal subsidy for most primary care
professionals (7). This was discussed during the session
of a successful non-federal oncology network—the
National Cancer Care Alliance (8)—where ﬁnancial
challenges faced by oncology-primary care partnerships
in research were described. Also, professional
enhancement can be stimulated through continuing
medical education credits from the AMA or American
Academy of Family Physicians related to the roles for
primary care professionals in research; this may also
potentially provide co-authorship opportunities.
Consider cancer prevention research presentations at
specialty meetings as opportunities for recruiting those
specialists who are pertinent for accruing patients.
Research Base study chairs may consider presenting their
proposals and/or results at meetings conducted by general
medical organization or specialties pertinent to the area
being investigated. For example, prostate prevention
protocols can be presented at urology meetings; cancer
prevention studies investigating cervical screening can be
presented at gynecological meetings. In addition, in quality
improvement sessions, prevention committee attendees
may advocate incorporating cancer prevention research as
a metric within the Merit-based Incentive Payment
System, the payment system in the Medicare Access and
CHIP Reauthorization Act (9).
Incentivize participation of community facilities.
Incorporating incentives into the protocol deemed as
relevant and desirable for the participating NCORP
clinics may attract other providers, clinic
administrators, and their patients. This ampliﬁes the
need for greater participation from primary care
professionals and non-oncology specialists at earlier
stages of protocol development, with anticipation that
these participating providers may identify incentives
deemed germane to various other clinics and practices.
Consider incentives based on current metrics recognized
by administrative management at healthcare facilities.
Petitions to administrative management for cancer
prevention protocols should appeal to administrative
interests by magnifying the merits of research in
community practice settings from a business perspective.
These requests may be buttressed by obtaining additional
funding from industry, the Patient-Centered Outcomes
Research Institute, or others, to offset potential
unanticipated budgetary challenges.
Promote the role of research as an extension of standardof-care that may serve as a vehicle to improved patient care
and longitudinal improvement in patient morbidity and
mortality outcomes. This suggestion during a workshop
session by an NCORP principal investigator and primary
care professional from the Baptist Memorial Health Care/
Mid-South Minority Underserved NCORP presented an
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eloquent lung screening study designed by and executed
at the site. The site created an amalgam of pragmatic
(e-mails) and innovative (Epic Medical Software) tools
integrated into their practice’s electronic lung cancer
early detection system. Within a few years of the study, a
signiﬁcant impact in lung cancer early detection was
achieved within their predominantly rural community.
This unique model can be extrapolated for use in
preventing other types of cancer with recognizable
risk factors.
7. Promote the community’s involvement in innovative
prevention research as a way to contribute to cancer
research advances (10). Introducing novel cancer
prevention approaches, such as immunoprevention, allows
Community Sites to broadly explore new areas while
contributing to the scientiﬁc efforts of the national cancer
program.
8. Explore ways to expand recruitment sites beyond
NCORP. Propose ideas to include the partnering of
NCORP investigators with Primary Care Practice-based
Research Networks, who represent a combination of
community-based practices with academic centers (11).
Another partnership to consider is the Patient-Centered
Outcomes Research Institute, which funds “research
that can help patients and those who care for them
make better-informed decisions about the healthcare
choices they face every day, guided by those who will
use that information” (12). Research Bases may consider
inviting sources for target-patient accrual, such as
clinical representatives from Federally Qualiﬁed Health
Centers and other safety net facilities. Such facilities
would enhance enrollment of underserved patients who
may be under-represented in cancer prevention
research.

afﬁliated clinical sites. This action serves to follow-up
three earlier recommendations mentioned for Research
Bases (in bullets #1, #2, and #4) to facilitate further
integration of the protocol into the practice. The
NCORP principal investigator must be aware of
feasibility concerns in primary care professionals’
clinical practice routines and convince them that the
protocol is compellingly beneﬁcial for integration within
the providers’ practices with minimal additional
infrastructures and complexities.
NCORP afﬁliate providers
Recommendations are as follows:
1. Enlist patient advocates and community health workers.
Patient advocates are recognized as profoundly inﬂuential
in cancer research, and community health workers are
inﬂuential among healthy volunteers. These advocates may
also play a role in protocol-development at the level of the
Research Base and Prevention Committees. The advocates
should be educated with the fundamentals of research but
also be able to engage within community settings. Those
who live within local communities, or at least share or are
familiar with the customs of community members, are
particularly inﬂuential.
2. Encourage “shared-decision making.” Shared-decision
making has been suggested as a model of patientcentered care, where patients’ goals and preferences are
central to ﬁnal decision-making in both medical care and
clinical trial participation. Patients can be informed
through evidence-based tools known as patient-decision
aids (13). In this context, partnership with the PatientCentered Outcomes Research Institute may prove
beneﬁcial.

NCORP principal investigators
Recommendations include the following:

Actionable items
Recommendations include the following.

1. Develop a “Research Champions” database of primary
care professionals and non-oncology specialists with
sustained interests in participating in prevention
research. This group would serve to encourage other
community providers to consider integrating prevention
research into their practices. The list can also serve as a
roster to help Research Bases identify pertinent
individuals to participate in concept and protocol
development.
2. Create supplementary educational modules for providers
who participate in NCORP cancer prevention research.
Some studies suggest that community providers may not
be as familiar with designing and conducting research
studies and could beneﬁt from learning fundamentals of
clinical research.
3. Engage with the practices’ administrative management
in identifying pertinent and desirable incentives for the

1. Research Bases can consider greater primary care
professional/relevant specialist input/involvement with
protocol development in the Prevention Committee for
the Research Base, providing incentives such as coauthorships and ﬁnancial remuneration, obtaining a roster
of PCP/Specialists for selecting participation in protocol
development, and Research Base activities such as CMEawarding educational sessions teaching the fundamentals
of research. In addition, patient representation, such as
community- and/or patient-advocates, is desirable at this
level as well.
2. Research Base principal investigators and study chairs
can attend and participate in primary care professionalsafﬁliated meetings and relevant specialists’ conferences.
Attendees can consider presenting on cancer prevention
sessions. These meetings might also provide the
opportunity to recruit other clinical representatives such
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as Federally Qualiﬁed Health Centers and other safety
net facilities, where enrollment of underserved and
underrepresented patients can be achieved.
3. Clinical and administrative management should be
included as stakeholders to promote cancer prevention
research and its importance in improving long-term
patient outcomes. Cancer prevention research can be
endorsed as beneﬁcial to community health by
identifying and investigating risk factors in patients that
lead to early detection of cancer, less-aggressive therapy
and better cancer outcomes. Finally, extolling the merits
of participating in precision prevention and
immunoprevention trials at the Community Sites can
bring national recognition for the NCOPR site’s
contribution in the advancement of oncology science.

Conclusions
The recommendations provided during the inaugural
PARTNRS Workshop, which address the problems derived
from the distinctive perspectives provided during the
collaborations sessions, may convert the perception of the
“Trickle-Down-Directives” on protocol development into
a more collaborative, transactional approach for NCORPfunded protocol development and implementation. Future
workshops will seek greater representation from national
family-physician organizations (i.e., the American Academy
of Family Physicians) and other non-oncology specialist
organizations, such as from obstetrics-gynecology, to
enhance understanding of the challenges and opportunities
facing community providers who are interested in participating in cancer prevention trials. More robust involvement
of ofﬁcial representatives from various national nononcology organizations could result in discussion of unanticipated problems such as infrastructural hindrances (i.e.,
need for clinical informatics that are compatible for identifying and recruiting potentially eligible participants). Such
representation could also provide alternative approaches to
improve patient enrollment, such as patient-stakeholder

engagement type of analysis used by the Patient-Centered
Outcomes Research Institute.
This is the ﬁrst of several PARTNRS Workshops aimed at
bringing about more fruitful partnerships between all groups
within the cancer care delivery system and the oncology
research realm. It is our fervent hope that these gatherings
will lead to more rapid fulﬁllment of accrual goals for community patients and all participants into cancer prevention
studies, and thereby improve and enhance public health.

Authors’ Disclosures
No disclosures were reported.

Acknowledgments
Members of the NCI PARTNRS Planning Committee are: Banu Arun1
James D. Bearden III, FACP2, Isabelle Bedrosian, FACS1, Carma L. Bylund,
FACH3, Mita Sanghavi Goel, MPH4, Tara Henderson, MPH5, Edward Bert
Knight2, Jenny J. Lin, MPH6, Ana María Lopez, MPH, FACP7, Barbara L.
McAneny FASCO, MACP8, Edith P. Mitchell, MACP, FCPP (co-chair)7,
Larissa Nekhlyudov, MPH9, Marian Neuhouser, RD10, Diane L. Padden,
CRNP, FAANP11, Archana Radhakrishnan, MHS12, Michael E. Roth1,
Christine Tracy, MSW11, and Marie Wood13
1
The University of Texas MD Anderson Cancer Center, Houston, Texas.
2
Spartanburg Regional Medical Center; Gibbs Cancer Center and
Research Institute Spartanburg, South Carolina.
3
University of Florida Cancer Center, Gainesville, Florida.
4
Feinberg School of Medicine, Northwestern University, Chicago,
Illinois.
5
The University of Chicago Medicine, Chicago, Illinois.
6
Icahn School of Medicine at Mount Sinai, New York, New York.
7
Sidney Kimmel Cancer Center of Jefferson Medical School, Thomas
Jefferson University, Philadelphia, Pennsylvania.
8
New Mexico Cancer Center, Albuquerque, New Mexico.
9
Harvard Medical School; Dana-Farber Cancer Institute, Boston,
Massachusetts.
10
Fred Hutchinson Cancer Research Center, Seattle, Washington.
11
American Association of Nurse Practitioners, Austin, Texas.
12
University of Michigan, Ann Arbor, Michigan.
13
University of Vermont Medical Center, Burlington, Vermont.
Received January 12, 2021; revised April 27, 2021; accepted August 5,
2021; published ﬁrst October 5, 2021.

References
1. Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J,
et al. The expanding role of primary care in cancer control.
Lancet Oncol 2015;16:1231–72.
2. Kleinpell R, Cook M, Padden DL. American Association of Nurse
Practitioners national nurse practitioner sample survey: update on
acute care nurse practitioner practice. J Am Assoc Nurse Pract 2018;
30:140–9.
3. Klabunde CN, Ambs A, Keating NL, He Y, Doucette WR, Tisnado D,
et al. The role of primary care physicians in cancer care. J Gen Intern
Med 2009;24:1029–36.
4. Mitchell EP. 2020 Vision: continuing declines in cancer incidence and
mortality rates. J Natl Med Assoc 2020;112:1–2.
5. Dossett LA, Hudson JN, Arden M, Lee MC, Roetzheim RG, Fetters
MD, et al. The primary care provider (PCP)-cancer specialist relationship: a systematic review and mixed methods meta-synthesis.
CA Cancer J Clin 2017;67:156–69.

AACRJournals.org

6. Bylund CL, Weiss ES, Michaels M, Patel S, D’Agostino TA,
Peterson EB, et al. Primary care physicians’ attitudes and beliefs
about cancer clinical trials. Clin Trials 2017;14:518–25.
7. What are relative value units (RVUs)? AAPC. Available from: https://
www.aapc.com/practice-management/rvus.aspx. Accessed March 29,
2021.
8. National Cancer Care Alliance, https://nccalliance.org/. Accessed
March 29, 2021.
9. American Academy of Professional CodersÔ website referencing
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Available from: https://www.aapc.com/macra/macra.aspx. Accessed
March 29, 2021.
10. LoConte NK, Gershenwald JE, Thomson CA, Crane TE, Harmon GE,
Rechis R. Lifestyle modiﬁcations and policy implications for primary
and secondary cancer prevention: diet, exercise, sun safety, and alcohol
reduction. ASCO Educational Book 2018;38:88–100.

Cancer Prev Res; 14(11) November 2021

Downloaded from cancerpreventionresearch.aacrjournals.org on December 7, 2021. © 2021 American Association for
Cancer Research.

981

Published OnlineFirst October 5, 2021; DOI: 10.1158/1940-6207.CAPR-21-0019

Parker et al.

11. Practice-Based Research Networks, Agency for Healthcare Research
and Quality. Available from: https://pbrn.ahrq.gov. Accessed March
29, 2021.
12. Patient-Centered Outcomes Research Institute. Available from:
https://www.pcori.org/. Accessed March 29, 2021.

982 Cancer Prev Res; 14(11) November 2021

13. Shared-Decision Making. Agency for Healthcare Research
and Quality. Available from: https://www.ahrq.gov/cahps/qualityimprovement/improvement-guide/6-strategies-for-improving/
communication/strategy6i-shared-decisionmaking.html. Accessed
March 29, 2021.

CANCER PREVENTION RESEARCH

Downloaded from cancerpreventionresearch.aacrjournals.org on December 7, 2021. © 2021 American Association for
Cancer Research.

Published OnlineFirst October 5, 2021; DOI: 10.1158/1940-6207.CAPR-21-0019

Establishing a Primary Care Alliance for Conducting Cancer
Prevention Clinical Research at Community Sites
Bernard W. Parker, Barbara L. McAneny, Edith P. Mitchell, et al.
Cancer Prev Res 2021;14:977-982. Published OnlineFirst October 5, 2021.

Updated version

E-mail alerts
Reprints and
Subscriptions
Permissions

Access the most recent version of this article at:
doi:10.1158/1940-6207.CAPR-21-0019

Sign up to receive free email-alerts related to this article or journal.
To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at
pubs@aacr.org.
To request permission to re-use all or part of this article, use this link
http://cancerpreventionresearch.aacrjournals.org/content/14/11/977.
Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC)
Rightslink site.

Downloaded from cancerpreventionresearch.aacrjournals.org on December 7, 2021. © 2021 American Association for
Cancer Research.

